If we look back to last year's budget and the commitment to $2.2 billion, which is in addition to the $1.6 billion that has been spent to date, that's the marker for funding the strategy. Of the $2.2 billion, approximately $1 billion is dedicated to various research undertakings, whether it's through supporting building out research infrastructure or through the Canada biomedical research fund or the clinical trials support.
Our strategy, executing on the strategy and rebuilding the sector are in many ways fuelled by the funding that was allocated in last spring's budget. We have lots or work ahead of us.